Johnson and Johnson Risperdal - Next Drug Cartel Member to pull an AstraZeneca - Seroquel

Johnson and Johnson (Risperdal) Next Drug Cartel Member to pull an AstraZeneca (Seroquel)

This is just another in the endless secession of the Big Players in the Pharmaceutical Drug Cartel getting caught illegally profiteering off the suffering of others. Once again for off label marketing and lying about their dangerous drugs with a myriad of life long horrific negative health consequences targeting the poor, elderly, and children. Do we even have to mention here J&J's Motrin phantom recall scandal, or the recent Child Tylenol recalls, or those fibs they told when appearing before Congress.

We now have more than enough evidence that our federal government is so internally conflicted taking Big Pharma corporate money, that our Government and their representatives are standing by doing almost nothing with their hands firmly planted in their pockets while our citizens health and lives are being handed over to these criminal corporations virtually unchecked. This time it took the State of Louisiana to bring a very small bit of justice forth.

The reported 258 million dollar figure is but mere pocket change to these criminals organizations after all; but if we were to expand these fines out to all 50 states it could put a significant wrinkle in the pharmaceutical corporate business as usual model now being employed with great profitable success.

Of course you can bet on appeals and years of legal wrangling before Big Pharma parts with any of their ill gotten bounty while continuing to pimp these very same profitable drugs at the tune of countless billions in profit per year. We also know by now that in that federal courts Big Pharma has much more influence and clout when we have a puppet government crying out that their political benefactors are just to big to fail.

The cold reality and hard facts speak a completely different truth: these criminal enterprises are just to big and corrupt not to fail in the end. It's really just a matter or the question of time when we the people decide we are not willing to be sold out to criminal corporations that are rubber stamped and protected by our sworn and elected servants.

What these fines do not include when reported in the news far to seldom, is the damage being done to citizens that can not be fixed by these criminals just writing a fat check. Your neighbors and community have been assaulted with serious health conditions including death caused directly by these criminal actions that will be with us for many many decades to come. The countless victims (including kids) lives that are destroyed are not being represented by our government or the criminal justice system. There is absolutely no price tag that can be placed upon those lives lost and the futures stolen.

They, like you are the forgotten ones, the throw away people that will never receive justice. If that is not enough to make you want to speak up and demand action, then I fear nothing will ever motivate you to do so. Enough said.



----------------------------------------------------------------------------------------
Via Pharmalot And pharmagossip

J&J To Pay $258 Million For Risperdal Marketing

A Louisiana state court jury has ordered Johnson & Johnson to pay $257.7 million for making misleading claims about the safety and superiority of its Risperdal antipsychotic and, consequently, defrauding the state’s Medicaid system, Bloomberg News writes.

The case centered on claims made by J&J and its Ortho-McNeil Janssen unit in letters sent in November 2003 to 700,000 doctors that touted Risperdal as safer than rival antipsychotics. The FDA then issued a warning letter that J&J made false and misleading claims minimizing potentially fatal risks of diabetes and overstated superiority. As a result, the jury found 35,542 violations of the state’s Medical Assistance Programs Integrity Law - comprising letters and phone calls to docs - and imposed a penalty of $7,250 for each, Bloomberg adds. The state sought a total of $351 million in damages.

This is the second trial loss for the health care giant in a state lawsuit brought over Risperdal marketing. A West Virginia judge in a non-jury trial last year awarded $4 million, which J&J is appealing. This past June, however, J&J won dismissal of a lawsuit brought by the state of Pennsylvania that charged side effect risks were hidden and state officials were fooled into paying millions more than they should have for the medicine

-------------------------------------------------------------------------------